Your browser doesn't support javascript.
loading
Recurrent ETV6::SYK rearrangement in myeloid malignancies confers partial susceptibility to MEK inhibition.
Manuelyan, Karen; Momcheva, Irina; Angelova, Svetlana; Nikolov, Krasimir; Shivarov, Velizar.
Affiliation
  • Manuelyan K; Department of Dermatology and Venereology, Medical Faculty, Trakia University and UMHAT "Prof. Dr. St. Kirkovich", Stara Zagora, Bulgaria.
  • Momcheva I; Department of Rheumatology Burgas, University "Prof. Dr. Asen Zlatarov" Burgas and UMHAT Burgas, Burgas, Bulgaria.
  • Angelova S; Laboratory of Cytogenetics and Molecular Biology, National Haematology Hospital, Sofia, Bulgaria.
  • Nikolov K; Department of Medical Oncology, Complex Oncology Center, Burgas, Bulgaria.
  • Shivarov V; Department of Experimental Research, Medical University Pleven, Pleven, Bulgaria.
Br J Haematol ; 205(1): 382-386, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38763512

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Repressor Proteins / Proto-Oncogene Proteins c-ets / Syk Kinase / ETS Translocation Variant 6 Protein Limits: Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2024 Document type: Article Affiliation country: Bulgaria

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Repressor Proteins / Proto-Oncogene Proteins c-ets / Syk Kinase / ETS Translocation Variant 6 Protein Limits: Female / Humans / Male / Middle aged Language: En Journal: Br J Haematol Year: 2024 Document type: Article Affiliation country: Bulgaria